Cholesterol Embolization
- 1 May 1967
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 35 (5) , 946-953
- https://doi.org/10.1161/01.cir.35.5.946
Abstract
In the 2 cases of multiple system disease due to atheromatous embolization presented, increasingly severe hypertension developed owing to renal involvement. One patient had acute pancreatitis from embolization to the pancreas. The 2nd patient had mottling of the skin of the legs. Purple toes were present and gangreen developed in 3 toes. The possible influence of anticoagulant therapy in promoting peripheral cholesterol embolism is discussed. It is suggested that the "purple toe syndrome" may be a manifestation of cholesterol embolization secondary to anticoagulant therapy.This publication has 14 references indexed in Scilit:
- Cholesterol embolismThe American Journal of Cardiology, 1965
- "Purple Toes": an Uncommon Sequela of Oral Coumarin Drug TherapyAnnals of Internal Medicine, 1961
- Disseminated atheromatous emboliThe American Journal of Medicine, 1960
- Spontaneous Atheromatous Embolization: Review of the Literature and a Report of 16 Additional CasesAmerican Journal of Clinical Pathology, 1960
- Atheromatous EmbolizationNew England Journal of Medicine, 1959
- Multiple Peripheral Emboli in Atherosclerosis of the AortaArchives of internal medicine (1960), 1959
- Atheromatous EmbolizationA.M.A. Archives of Surgery, 1957
- Atheromatous Emboli to the Kidneys after Aortic SurgeryNew England Journal of Medicine, 1957
- Clinical and pathologic significance of atheromatous embolization, with emphasis on an etiology of renal hypertensionThe American Journal of Medicine, 1956
- EMBOLIZATION WITH MATERIAL FROM ATHEROMATAThe Lancet Healthy Longevity, 1949